BIOMARIN PHARMACEUTICAL INC (BMRN) Common Stock, Shares, Outstanding 2010 - 2024

Historical data

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Biomarin Pharmaceutical Inc quarterly Common Stock, Shares, Outstanding history and growth rate from 2010 to 2024.
  • Biomarin Pharmaceutical Inc Common Stock, Shares, Outstanding for the quarter ending March 31, 2024 was 190 M shares, a 1.16% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly Data (shares)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 190 M +2.18 M +1.16% Mar 31, 2024 10-Q 2024-04-26
Q4 2023 189 M +2.35 M +1.26% Dec 31, 2023 10-Q 2024-04-26
Q3 2023 188 M +2.52 M +1.35% Sep 30, 2023 10-Q 2023-11-02
Q2 2023 188 M +2.7 M +1.46% Jun 30, 2023 10-Q 2023-08-02
Q1 2023 188 M +2.7 M +1.46% Mar 31, 2023 10-Q 2023-04-28
Q4 2022 186 M +2.34 M +1.27% Dec 31, 2022 10-K 2024-02-26
Q3 2022 186 M +2.26 M +1.23% Sep 30, 2022 10-Q 2022-10-28
Q2 2022 185 M +2.13 M +1.16% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 185 M +2.23 M +1.22% Mar 31, 2022 10-Q 2022-04-29
Q4 2021 184 M +2.17 M +1.2% Dec 31, 2021 10-K 2023-02-27
Q3 2021 184 M +2.08 M +1.14% Sep 30, 2021 10-Q 2021-10-29
Q2 2021 183 M +2.17 M +1.2% Jun 30, 2021 10-Q 2021-07-30
Q1 2021 183 M +1.91 M +1.06% Mar 31, 2021 10-Q 2021-04-30
Q4 2020 182 M +1.9 M +1.06% Dec 31, 2020 10-K 2022-02-25
Q3 2020 181 M +1.89 M +1.05% Sep 30, 2020 10-Q 2020-11-06
Q2 2020 181 M +1.72 M +0.96% Jun 30, 2020 10-Q 2020-08-05
Q1 2020 181 M +1.73 M +0.97% Mar 31, 2020 10-Q 2020-05-01
Q4 2019 180 M +1.59 M +0.89% Dec 31, 2019 10-K 2021-02-26
Q3 2019 180 M +1.7 M +0.96% Sep 30, 2019 10-Q/A 2019-11-04
Q2 2019 179 M +1.93 M +1.09% Jun 30, 2019 10-Q 2019-08-02
Q1 2019 179 M +2.38 M +1.35% Mar 31, 2019 10-Q 2019-04-29
Q4 2018 178 M +2.41 M +1.37% Dec 31, 2018 10-K 2020-02-27
Q3 2018 178 M +2.41 M +1.37% Sep 30, 2018 10-Q 2018-10-26
Q2 2018 178 M +2.26 M +1.29% Jun 30, 2018 10-Q 2018-08-03
Q1 2018 177 M +3.35 M +1.93% Mar 31, 2018 10-Q 2018-04-27
Q4 2017 176 M +3.2 M +1.85% Dec 31, 2017 10-K 2019-02-28
Q3 2017 175 M +3.8 M +2.21% Sep 30, 2017 10-Q 2017-10-31
Q2 2017 175 M +12 M +7.33% Jun 30, 2017 10-Q 2017-08-02
Q1 2017 173 M +11.1 M +6.82% Mar 31, 2017 10-Q 2017-05-04
Q4 2016 173 M +11.1 M +6.89% Dec 31, 2016 10-K 2018-02-26
Q3 2016 172 M +10.5 M +6.5% Sep 30, 2016 10-Q 2016-11-03
Q2 2016 163 M +2.27 M +1.41% Jun 30, 2016 10-Q 2016-08-08
Q1 2016 162 M +1.96 M +1.22% Mar 31, 2016 10-Q 2016-05-02
Q4 2015 162 M +12.4 M +8.34% Dec 31, 2015 10-K 2017-02-27
Q3 2015 161 M +13.8 M +9.36% Sep 30, 2015 10-Q 2015-11-02
Q2 2015 161 M +13.9 M +9.48% Jun 30, 2015 10-Q 2015-08-05
Q1 2015 160 M +14.5 M +9.98% Mar 31, 2015 10-Q 2015-05-05
Q4 2014 149 M +5.63 M +3.92% Dec 31, 2014 10-K 2016-02-29
Q3 2014 147 M +5.23 M +3.68% Sep 30, 2014 10-Q 2014-10-28
Q2 2014 147 M +7.02 M +5.01% Jun 30, 2014 10-Q 2014-07-31
Q1 2014 146 M +6.87 M +4.94% Mar 31, 2014 10-Q 2014-05-02
Q4 2013 143 M +17.7 M +14% Dec 31, 2013 10-K 2015-03-02
Q3 2013 142 M +18.4 M +14.9% Sep 30, 2013 10-Q 2013-10-28
Q2 2013 140 M +16.8 M +13.6% Jun 30, 2013 10-Q 2013-07-29
Q1 2013 139 M +23.2 M +20% Mar 31, 2013 10-Q 2013-04-29
Q4 2012 126 M +11 M +9.6% Dec 31, 2012 10-K 2014-02-26
Q3 2012 124 M +9.64 M +8.45% Sep 30, 2012 10-Q 2012-10-29
Q2 2012 123 M +11.7 M +10.5% Jun 30, 2012 10-Q 2012-08-02
Q1 2012 116 M +4.81 M +4.34% Mar 31, 2012 10-Q 2012-04-30
Q4 2011 115 M +4.16 M +3.76% Dec 31, 2011 10-K 2013-02-26
Q3 2011 114 M +11.7 M +11.4% Sep 30, 2011 10-Q 2011-10-31
Q2 2011 112 M +9.55 M +9.36% Jun 30, 2011 10-Q 2011-08-01
Q1 2011 111 M Mar 31, 2011 10-Q 2011-04-29
Q4 2010 111 M Dec 31, 2010 10-K 2012-02-22
Q3 2010 102 M Sep 30, 2010 10-Q 2010-10-29
Q2 2010 102 M Jun 30, 2010 10-Q 2010-08-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.